Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
37,563,590
-
Share change
-
-1,191,442
-
Total reported value
-
$40,942,218
-
Price per share
-
$1.09
-
Number of holders
-
29
-
Value change
-
-$1,294,868
-
Number of buys
-
10
-
Number of sells
-
11
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q4 2017
As of 31 Dec 2017,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,563,590 shares.
The largest 10 holders included
BVF INC/IL, Senvest Management, LLC, MORGAN STANLEY, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, Opaleye Management Inc., Benchmark Capital Advisors, ETF MANAGERS GROUP, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.